Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TCDD-inducible poly(ADP-ribose) polymerase (TIPARP, also known as Poly(ADPr)-polymerase 7 or PARP7), is a member of the poly(ADPr)-polymerases (PARPs), a protein family involved in post-translational modification through ADPr transfer from NAD+ onto substrate proteins. Unlike canonical members such as PARP1 that catalyze formation of long branched polymers ("poly"-ribosylation), TIPARP primarily mediates mono ADPr transfer ("mono"-ribosylation). The biological functions attributed to this enzyme include regulation of gene expression via chromatin remodeling and modulation of cellular responses following exposure to environmental toxins such as dioxins. While much research has focused on other family members like PARP1/2 due to their central role in DNA repair pathways—and thus their value as cancer drug targets—emerging evidence suggests that selective inhibition or modulation of enzymes like TIPARP could have therapeutic potential but requires further study regarding specificity, efficacy, and safety profiles. Note: The submitted name "Poly polymerase 7" does not conform with accepted nomenclature; the correct designation should be TCDD-inducible poly(ADPr)-polymerase (TIPARP/PARP7).
For general PARPs: Inhibition leads to impaired DNA repair and synthetic lethality in cells with defective homologous recombination. For TIPARP: Likely involves inhibition of mono ADP-ribosylation activity on specific substrates.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TCDD-inducible poly(ADP-ribose) polymerase (TIPARP).